Nominate: Xconomy Awards →
May 13, 2020 · Boston
June 11, 2020 · New York
June 25, 2020 · San Francisco
Guy Macdonald is CEO of Tetraphase Pharmaceuticals
Sponsored · Whitepaper
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
© 2007-2020, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.